A Canadian primary care sentinel surveillance network study evaluating antidepressant prescribing in Canada from 2006 to 2012

Canadian Journal of Psychiatry

Volumn 60, Issue 12, 2015, Pages 564-570

  Morkem, Rachael ^a   Barber, David ^a   Williamson, Tyler ^b   Patten, Scott B ^b,c,d  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c University of Calgary ^*  (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antidepressant drugs; Canadian primary care sentinel surveillance network; Electronic medical record; Primary care

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CANADA; CROSS-SECTIONAL STUDY; DEPRESSION; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; SENTINEL SURVEILLANCE; AGED; CLINICAL PRACTICE; DEPRESSIVE DISORDER, MAJOR; ELECTRONIC HEALTH RECORD; FACTUAL DATABASE; PRIMARY HEALTH CARE; PROTOCOL COMPLIANCE; STATISTICS AND NUMERICAL DATA; SUPERIOR SAGITTAL SINUS; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CANADA; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DEPRESSIVE DISORDER, MAJOR; ELECTRONIC HEALTH RECORDS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SENTINEL SURVEILLANCE; SUPERIOR SAGITTAL SINUS; YOUNG ADULT;

EID: 84949550827     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371506001207     Document Type: Article

References (33)

1. Ustun TB, Ayuso-Mateos JL, Chatterji S, et al. Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004;184:386-392.
2. Kennedy SH, Lam RW, Parikh S V, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. J Affect Disord. 2009;117:S1-S2.
3. Cuijpers P, Beekman ATF, Reynolds CF. Preventing depression. A global priority. JAMA. 2012;307(10):1033-1034.
4. Beck CA, Patten SB, Williams JV, et al. Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol. 2005;40:99-807.
5. Mojtabai R, Olfson M. Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood). 2011;30(8):1434-1442.
6. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. JAMA. 2004;291:2581-2590.
7. Laukkala T, Isometsä E, Hämäläinen J, et al. Antidepressant treatment of depression in the Finnish general population. Am J Psychiatry. 2001;158:2077-2079
8. Young AS, Klap R, Sherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001;58:55-61.
9. Patten SB, Beck C. Major depression and mental health care utilization in Canada: 1994 to 2000. Can J Psychiatry. 2004;49:303-309.
10. Katz SJ, Kessler RC, Lin E, et al. Medication management of depression in the United States and Ontario. J Gen Intern Med. 1998;13:77-85.
11. Baumesiter H. Inappropriate prescriptions of antidepressant drugs in patients with subthreshold to mild depression: time for the evidence to become practice. J Affect Disord. 2012;139:240-243.
12. Katon W, Ciechanowski P. Unipolar major depression in adults: choosing initial treatment. In: Solomon D, editor. UpToDate. Wellesley (MA): UpToDate; 2014.
13. GlaxoSmithKline Inc. Important drug warning: until further information is available, Paxil® (paroxetine hydrochloride) should not be used in children and adolescents under 18 years of age [Internet]. Mississauga (ON): GlaxoSmithKline Inc; 2003 [cited 2013 May 10]. Available from: http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2003/14226a-eng.php.
14. Birmaher B, Bridge JA, Williamson DE, et al. Pyschosocial functioning in youths at high risk to develop major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2004;43(7):839-846.
15. Gould MS, King R, Greewald S, et al. Psychopathology associated with suicidal ideation and attempts among children and adolescents. J Am Acad Child Adolesc Psychiatry. 1998;37(9):915-923.
16. Lewinson PM, Rohde P, Klein DN, et al. Natural course of adolescent major depressive disorder: continuity into adulthood. J Am Acad Child Adolesc Psychiatry. 1999;38(1):56-63.
17. Fiest KM, Currie SR, Williams JV, et al. Chronic conditions and major depression in community-dwelling older adults. J Affect Disord. 2011;131(1-3):172-178.
18. Terner M, Reason B, McKeag AM, et al. Chronic conditions more than age drive health system use in Canadian seniors. Healthc Q. 2011;14(3):19-23.
19. Raymond CB, Morgan SG, Caetano PA. Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatr Serv. 2007;58:79-84.
20. Blier P. The well of novel antidepressants: running dry. J Psychiatry Neurosci. 2010;35(4):219-220.
21. Katz LY, Kozyrskyj AL, Prior HJ, et al. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. CMAJ. 2008;178(8):1005-1011.
22. Patten SB, Wang JL, Williams JV, et al. Descriptive epidemiology of major depression in Canada. Can J Psychiatry. 2006;51(2):84-90.
23. Patten SB, Esposito E, Carter B. Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiol Drug Saf. 2007;16:746-752.
24. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66:848-856.
25. Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med. 2006;166(9):1021-1026.
26. Eguale T, Buckeridge DL, Winslade NE, et al. Drug, patient, and physician characteristics associated with off-label prescribing in primary care. Arch Intern Med. 2012;172(10):781-788.
27. Doherty DT, Kartalova-O'Doherty Y. Gender and self-reported mental health problems: predictors of help-seeking from a general practitioner. Br J Health Psychol. 2010;15(Pt 1):213-228.
28. Hankin B. Future directions in vulnerability to depression among youth: integrating risk factors and processes across multiple levels of analysis. J Clin Child Adolesc Psychol. 2012;41(5):695-718.
29. Moore M, Ming-Huen H, Dunn N, et al. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ. 2009;339:b3999.
30. McManus P, Mant A, Mitchell PB, et al. Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Med J Aust. 2000;173:458-461.
31. Delaney JA, Oddson BE, McClelland RL, et al. Estimating ethnic differences in self-reported new use of antidepressant medications: results from Multi-Ethnic Study of Atherosclerosis. Pharmaocepidemiol Saf. 2009;18; 545-553.
32. Trifiro G, Barbui C, Spina E, et al. Antidepressant drugs: prevalence, incidence and indication of use in general practice in southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf. 2007;16:552-559.
33. Wu CS, Shau WY, Chan HY, et al. Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009. Pharmacoepidemiol Drug Saf. 2012;21:980-988.